Literature DB >> 24072727

Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia.

S L Brennan1, M A Kotowicz, B Sarah, W D Leslie, P R Ebeling, C J Metge, A G Dobbins, J A Pasco.   

Abstract

UNLABELLED: In 2007, Medicare Australia revised rei:mbursement guidelines for dual energy X-ray absorptiometry (DXA) for Australians aged ≥70 years; we examined whether these changes increased DXA referrals in older adults. Proportions of DXA referrals doubled for men and tripled for women from 2003 to 2010; however, rates of utilization remained low.
INTRODUCTION: On April 1, 2007 Medicare Australia revised reimbursement guidelines for DXA for Australians aged ≥70 year; changes that were intended to increase the proportion of older adults being tested. We examined whether changes to reimbursement increased DXA referrals in older adults, and whether any sex differences in referrals were observed in the Barwon Statistical Division.
METHODS: Proportions of DXA referrals 2003-2010 based on the population at risk ascertained from Australian Census data and annual referral rates and rate ratios stratified by sex, year of DXA, and 5-year age groups. Persons aged ≥70 years referred to the major public health service provider for DXA clinical purposes (n = 6,096; 21 % men).
RESULTS: DXA referrals. Proportions of DXA referrals for men doubled from 0.8 % (2003) to 1.8 % (2010) and tripled from 2.0 to 6.3 % for women (all p < 0.001). For 2003-2006, referral ratios of men/women ranged between 1:1.9 and 1:3.0 and for 2007-2010 were 1:2.3 to 1:3.4. Referral ratios <2007:≥2007 were 1:1.7 for men aged 70-79 years (p < 0.001), 1:1.2 for men aged 80-84 years (p = 0.06), and 1:1.3 for men 85+ years (p = 0.16). For women, the ratios <2007:≥2007 were 1:2.1 (70-79 years), 1.1.5 (80-84 years), and 1:1.4 (85+ years) (all p < 0.001).
CONCLUSIONS: DXA referral ratios were 1:1.6 (men) and 1:1.8 (women) for 2007-2010 vs. 2003-2006; proportions of referrals doubled for men and tripled for women from 2003 to 2010. Overall, rates of DXA utilization remained low. Policy changes may have had minimal influence on referral; thus, ongoing evaluation over time is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 24072727     DOI: 10.1007/s11657-013-0152-1

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  4 in total

1.  Future Osteoporotic Fracture Risk Related to Lumbar Vertebral Trabecular Attenuation Measured at Routine Body CT.

Authors:  Scott J Lee; Peter M Graffy; Ryan D Zea; Timothy J Ziemlewicz; Perry J Pickhardt
Journal:  J Bone Miner Res       Date:  2018-02-05       Impact factor: 6.741

2.  Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.

Authors:  Ja Seo Koo; Seong Hwan Moon; Hankil Lee; Sohee Park; Yun Mi Yu; Hye-Young Kang
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

3.  Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea.

Authors:  Young-Seung Ko; Yeonsuk Jeong; Jung-Wee Park; Young-Kyun Lee; Kyung-Hoi Koo
Journal:  J Bone Metab       Date:  2022-08-31

4.  Determinants of Bone Mineral Screening Behavior among Three Ethno-Cultural Groups of Women in Israel.

Authors:  Offer E Edelstein; Netta Achdut; Iris Vered; Orly Sarid
Journal:  Int J Environ Res Public Health       Date:  2020-08-24       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.